Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.
N/A
18 Years
70 Years
18 Years
70 Years
Open (Enrolling)
Both
Hepatocellular Carcinoma
Both
Hepatocellular Carcinoma
Trial Information
Body Composition Analysis by Bioelectrical Impedance Vector Analysis in Patients With Hepatocellular Carcinoma Undergoing Chemoembolization.
Inclusion Criteria:
- Patients with hepato-renal disease
- Patients with hepatocellular carcinoma that are put down to radiofrequency
ablation
- Patients with depression or any psiquiatric disease.
- Patients that don't agree to participate in the project.
Exclusion Criteria:
- Patients with hepatocellular carcinoma that are put down to radiofrequency
ablation
- Patients with depression or any psiquiatric disease.
- Patients that don't agree to participate in the project.
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
Changes in body composition
Outcome Description:
To evaluate any changes in corporal composition in patients undergoing chemoembolization.
Outcome Time Frame:
1 hour before treatment, 2 weeks after treatment, and 1 month after treatment
Safety Issue:
No
Principal Investigator
Aldo Torre, M.D, M.Sc.
Investigator Role:
Study Chair
Investigator Affiliation:
Instituto Nacional de Nutrición y Ciencias Médicas "Salvador Zubirán"
Authority:
Mexico: Ethics Committee
Study ID:
QMECR1
NCT ID:
NCT01777698
Start Date:
April 2012
Completion Date:
October 2013
Related Keywords:
- Hepatocellular Carcinoma
- body composition
- hepatocellular carcinoma
- chemoembolization
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|
